Evidence map›Paper›PMID 41606768›Full record

ArticleBMC surgery2026

SPY-QP-guided perfusion assessment to prevent esophagogastric anastomotic leakage: protocol for the SPYMIE study.

Tomoaki Aoki, Hironobu Goto, Yasufumi Koterazawa, Masayuki Ando, Yutaka Sugita, Taro Ikeda, Hitoshi Harada, Yasunori Otowa, Naoki Urakawa, Hiroshi Hasegawa and 4 more

Abstract read
In one paragraph

Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tomoaki AokiDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Hironobu GotoDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. hirogoto@med.kobe-u.ac.jp.
Yasufumi KoterazawaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Masayuki AndoDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Yutaka SugitaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Taro IkedaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Hitoshi HaradaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Yasunori OtowaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Naoki UrakawaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Hiroshi HasegawaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Shingo KanajiDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Kimihiro YamashitaDivision of Analytical Biomedical Sciences, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan.
Takeru MatsudaDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Yoshihiro KakejiDivision of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEsophagectomy with gastric conduit reconstruction is one of the standard treatment for esophageal cancer; however, anastomotic leakage remains a major complication, occurring in approximately 13% of cases. Impaired perfusion of the gastric conduit is a key risk factor, highlighting the need for objective intraoperative blood flow assessment. Although indocyanine green (ICG) fluorescence imaging has been used, quantitative evaluation is lacking, and perfusion of the remnant esophagus has not been assessed. The SPY-QP system provides objective, real-time perfusion analysis using fluorescence intensity metrics. This study examines the role of SPY-QP–guided perfusion assessment in supporting intraoperative anastomotic decision-making and explores its association with a reduced incidence of anastomotic leakage compared with conventional near-infrared evaluation.

methodsThis investigator-initiated, prospective, single-arm clinical study (SPYMIE study) aims to evaluate the feasibility and effectiveness of quantitative perfusion assessment using the SPY-QP fluorescence system during minimally invasive esophagectomy for esophageal cancer. Intraoperative ICG fluorescence imaging is performed to quantify blood flow in the gastric conduit and remnant esophagus. The primary endpoint is the incidence of anastomotic leakage, with secondary outcomes including anastomotic stricture, gastric conduit necrosis, and relative fluorescence intensity at anastomotic sites. Historical controls with conventional near-infrared evaluation will be used for comparison. DISCUSSION: Anastomotic leakage after minimally invasive esophagectomy remains a major concern, largely attributed to inadequate perfusion at the anastomotic site. Conventional intraoperative assessments are subjective and lack quantitative reliability. The SPY-QP system enables real-time, quantitative perfusion analysis, providing measurable parameters such as relative ICG fluorescence intensity and time-to-peak intensity. Prior studies demonstrated that SPY-QP detects low-perfusion regions unseen with qualitative imaging and influences surgical decision-making, leading to reduced leakage rates. Therefore, SPY-QP–guided quantitative perfusion assessment may enhance intraoperative blood flow evaluation of anastomotic sites, standardize perfusion-based surgical quality indicators in esophagectomy.

trial registrationThis SPYMIE study was prospectively registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN-CTR) on May 12, 2025 (registration number: UMIN000057825) under the title “Prospective, single-arm study on the usefulness of blood flow evaluation of the gastric conduit and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer.”

Indexed as

Anastomotic LeakEsophageal NeoplasmsEsophagectomyEsophagusOptical ImagingStomachAnastomosis, SurgicalFeasibility StudiesHumansIndocyanine GreenProspective StudiesIndocyanine GreenAnastomotic leakageEsophageal cancerMinimally invasive esophagectomySPY-QP

Identifiers

PMID41606768
PMCPMC12922395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.